Asia Biomaterials (Wuhan) Co., Ltd. is a core medical device enterprise in China Optics Valley Biocity, a listed "golden seed enterprise" in Hubei Province, and a "gazelle enterprise" in Wuhan City. It has 4 holding companies, three independent business divisions, and one overseas company. The base includes two national high-tech enterprises. 

Asia Bio Group has world-class GMP 10,000-level production line facilities, a new product base building with a total area of more than 10,000 square meters, and a "High-end Biomaterials Equipment International Joint Laboratory" and two provincial and ministerial level R&D platforms - Hubei Provincial Bioactive Materials The Device Research Institute and the Hubei Provincial Engineering Research Center for Oral and Maxillofacial Medical Devices and Equipment are the largest calcium-phosphorus bioactive material production base in Asia and have established overseas cooperative R&D centers and bases in the United States, Australia and South Korea. The company has successively undertaken major national key projects such as the National Key R&D Program Project, the National “863” High-tech Development Program Project, the National Science and Technology Support Program Project, and the Ministry of Science and Technology Inter-Governmental International Cooperation Program Project, representing technological innovation and innovation in the field of high-end biomaterial equipment. National level of transformation. The company has the research and development and development of more than 10 kinds of biomaterial device products, including highly active bone repair material and device series (Eucosyn®, Jincos®, Recosyn®), Yafukang® wound repair material product series, oral repair material product series, etc. With high production capacity, it is a representative high-tech enterprise in the field of independent innovation of medical devices in my country.